Fox News’ Megyn Kelly to keynote NACDS Foundation dinner
ARLINGTON, Va. — The National Association of Chain Drug Stores announced Thursday that Fox News anchor Megyn Kelly would give the keynote address at the NACDS Foundation dinner. The annual event, put on by the organization’s charity arm, is now in its 17th year and takes place Dec. 3 in New York City. Kelly is the host of “The Kelly File,” the second-most-watched cable news show on television.
“Not afraid to ask the tough questions, Megyn Kelly has spent her television career breaking news, cutting through the news clutter and delivering in-depth investigative reporting that resonates with millions of viewers nationwide,” NACDS Foundation president Kathleen Jaeger said. “From her coverage of national and political news to her interviews with newsmakers and national leaders, we look forward to hearing more about how those experiences have shaped her coverage of the news.”
Kelly has been with Fox News in some capacity since 2004 and in 2009 and 2010 co-anchored its coverage of Elena Kagan’s and Sonia Sotomayor’s Supreme Court confirmation hearings. In 2012 and 2014, she co-anchored Fox News’ election coverage. Before starting her career in journalism, Kelly was a corporate attorney.
PrescribeWellness to participate in its first annual National Open Enrollment Week
IRVINE, Calif. – PrescribeWellness, the cloud-based services company whose mission is to inspire collaboration for better health, recently announced their participation in the first annual National Open Enrollment Week.
“We are very excited to be participating in National Open Enrollment Week,” shared Al Babbington, CEO of PrescribeWellness. “As Medicare options continue to get more complicated for seniors, many patients are looking for answers from a healthcare professional they can trust. National Open Enrollment Week is a great opportunity for us to showcase our PrescribeMedicare product which empowers our pharmacy clients to answer those questions and make a positive impact on their Medicare-eligible patients and their community.”
PrescribeWellness will take part in National Open Enrollment Week by providing marketing materials for their participating pharmacies. In addition, they will provide free access to their plan finder product, PrescribeMedicare, for their pharmacy partners during the entire week. This will give their pharmacies the ability to provide Medicare Advantage and prescription drug plan reviews for their Medicare-eligible patients.
National Open Enrollment Week is set for Nov. 1-7, 2015.
National Open Enrollment Week is a nationwide event designed to inform Medicare-eligible seniors that they can turn to the most accessible and trusted healthcare providers, their pharmacist, to help them identify the right Medicare plan. During this time, patients will be encouraged to reach out to their local community pharmacists for information regarding the available Medicare options that work in conjunction with their current prescriptions.
Allergan confirms merger talks with Pfizer
DUBLIN — Allergan on Thursday confirmed that it is currently in talks with Pfizer regarding a potential combination of the two drug makers. A statement from the company said that it had been approached by Pfizer to discuss a transaction. Allergan did not offer any comment on the potential terms of an agreement or whether one would take place.
A deal, if reached this year, would be the second big deal for Allergan in 2015, as earlier this year, it reached an agreement to sell its generics business to Israeli drug maker Teva — a deal that Allergan noted is still taking place regardless of what happens with Pfizer. The Teva deal is set to close in the first quarter of 2016, the company said.
The news of Pfizer approaching Allergan comes at a time in which consolidation among drug companies is a growing trend.r Earlier this year, When Teva announced its Allergan Generics acquisition, it had been working to acquire Mylan, but dropped that bid in favor of the Allergan deal. And at the sametime that it was fending off an acquisition from Teva, Mylan was attempting to purchase Ireland-based Perrigo, a venture that Mylan is still pursuing, having recently tendered a $27 billion offer directly to Perrigo shareholders.
Allergan said that it would make further announcements regarding its talks with Pfizer when they were appropriate.
Loading Post Please Wait...